The maker of ivermectin/pyrantel, the #1 vet-recommended and #1 dog-preferred real beef chew introduces the latest innovation in its portfolio
Luforbec® 100/6 pMDI aims to provide comprehensive support to patients and healthcare professionals
Pfizer will make upfront and milestone payments, as well as pay royalties on sales of resulting therapeutics
CMOs showed an increasing reluctance to take on debt in 2022
To equip them with the latest knowledge and skills to handle patients coming to them in a better way
Planned investment of approximately USD 90 million to build a state-of-the-art Sandoz Biosimilar Technical Development Center in Ljubljana, Slovenia by 2026
Long COVID is a debilitating chronic condition that has affected over 100 million people globally
First of its kind screening for Glaucoma at grass root level over 10k screened already
Moist wound dressing for chronic wound treatment now available in Germany
Evonik specializes in mid- to large-scale, later clinical phase HPAPIs
Subscribe To Our Newsletter & Stay Updated
